Research location
Airdrie
United Kingdom
Advertisement
Research activity in Airdrie
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 31 trials and 32 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Airdrie
31 linked trials · page 1 of 1A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusNCT07776509 · 2026-08-24 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesNCT07351045 · 2026-03-16 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionNCT06307652 · 2024-04-12 · 1 site observation
RECRUITING
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)NCT06077864 · 2023-11-20 · 1 site observation
COMPLETED
Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart FailureNCT05419115 · 2022-11-17 · 1 site observation
COMPLETED
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -VNCT04870333 · 2021-02-19 · 1 site observation
COMPLETED
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 1 site observation
COMPLETED
Lowering Events in Non-proliferative Retinopathy in ScotlandNCT03439345 · 2018-07-23 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart FailureNCT03036124 · 2017-02-08 · 1 site observation
COMPLETED
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday LifeNCT03000192 · 2016-08-01 · 1 site observation
UNKNOWN
Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMANNCT02642562 · 2016-08-01 · 1 site observation
COMPLETED
Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using ToujeoNCT02585674 · 2015-12-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)NCT02585778 · 2015-10-23 · 1 site observation
COMPLETED
An Evaluation of Web Based Pulmonary RehabilitationNCT02404831 · 2014-04-01 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureNCT01877915 · 2013-09-10 · 1 site observation
COMPLETED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.NCT01602380 · 2012-10-17 · 1 site observation
COMPLETED
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - DiabetesNCT01272232 · 2011-06-01 · 1 site observation
COMPLETED
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation
COMPLETED
Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational StudyNCT00949286 · 2010-01-01 · 1 site observation
COMPLETED
Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®NCT00542880 · 2007-09-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular SafetyNCT00359801 · 2006-07-01 · 1 site observation
COMPLETED
Insulin Resistance Intervention After Stroke TrialNCT00091949 · 2005-02-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionNCT00160212 · 2004-12-01 · 1 site observation
COMPLETED
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 DiabetesNCT00184600 · 2004-11-01 · 1 site observation
COMPLETED
SPIRIVA in Ususal CareNCT00274079 · 2002-10-01 · 1 site observation
COMPLETED
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesNCT00379769 · 2001-04-01 · 2 site observations
COMPLETED
Safety and Efficacy of Insulin Aspart in Subjects With Type 1 DiabetesNCT01707134 · 1997-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.